Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992;124(1-2):21-30.
doi: 10.1007/BF01314622.

Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF

Affiliations

Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF

I Kurane et al. Arch Virol. 1992.

Abstract

Dengue virus is transmitted to humans by the bite of infected mosquitos. In our efforts to understand the pathogenesis of dengue virus infection, we examined whether skin fibroblasts can be infected in vitro with dengue viruses. Fibroblasts could be infected with dengue viruses, yellow fever virus and West Nile virus. Dengue virus antigen-positive cells were detected as early as 4 h and the percentage of dengue virus antigen-positive cells reached maximum levels by 24 h after infection. High titers of infectious dengue virus were also detected in the culture supernatants at 20 h after infection. Dengue virus-infected fibroblasts produced interferon-beta (IFN-beta), and the IFN-beta protected uninfected fibroblasts from dengue virus infection. Dengue virus-infected fibroblasts also produced interleukin 6 (IL-6) and granulocyte macrophage colony stimulation factor (GM-CSF). These results suggest that skin fibroblasts may be one of the cell types which first support dengue virus and other flavivirus infections in vivo after introduction by the bite of infected mosquito, and that production of IFN-beta, IL-6, and GM-CSF by these virus-infected fibroblasts may be important host immune responses to control flavivirus infections.

PubMed Disclaimer

References

    1. Nature. 1986 Nov 6-12;324(6092):73-6 - PubMed
    1. Am J Trop Med Hyg. 1982 Jul;31(4):830-6 - PubMed
    1. J Immunol. 1988 Jan 15;140(2):508-12 - PubMed
    1. Science. 1986 Apr 25;232(4749):506-8 - PubMed
    1. J Virol. 1984 Oct;52(1):223-30 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources